William G. Harris's most recent trade in Soleno Therapeutics Inc was a trade of 3,991 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 3,991 | 19,392 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 6,500 | 15,401 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 10,000 | 10,000 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 2,666 | 2,666 | - | - | Stock option (right to buy) | |
| Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 42,254 | 146,870 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | William G. Harris | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. | 31 Jan 2022 | 13,352 | 133,518 (0%) | 0% | 0.4 | 4,740 | Common Stock |
| Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 20,167 | 110,989 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | William G. Harris | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.74 per share. | 29 Oct 2021 | 6,373 | 104,616 (0%) | 0% | 0.7 | 4,740 | Common Stock |
| Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 16,484 | 96,032 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | William G. Harris | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.91 per share. | 30 Jul 2021 | 5,210 | 90,822 (0%) | 0% | 0.9 | 4,741 | Common Stock |
| Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 31,862 | 31,862 | - | - | Employee stock option (right to buy) | |
| Soleno Therapeutics Inc | William G. Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 12,397 | 83,466 (0%) | 0% | 0 | Common Stock | |
| Soleno Therapeutics Inc | William G. Harris | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. | 30 Apr 2021 | 3,918 | 79,548 (0%) | 0% | 1.2 | 4,741 | Common Stock |